Social Capital Suvretta Holdings Corp IV Cl A (DNAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | DNAD | SGMT | OBIO | ||
| Company | Social Capital Suvretta Holdings Corp IV Cl A | Sagimet Biosciences Inc Series A | Orchestra Biomed Hldgs Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 10.35 | 10.48 | 5.53 | ||
| High | 10.36 | 10.64 | 5.58 | ||
| Low | 10.34 | 10.15 | 5.38 | ||
| Last | 10.35 | 10.18 | 5.43 | ||
| Change | +0.01 | -0.40 | -0.12 | ||
| Percent Change | +0.10% | -3.78% | -2.16% | ||
| Volume | 144,200 | 1,138,700 | 209,500 | ||
| 20-Day Average Volume | 127,825 | 1,310,765 | 293,275 | ||
| Previous | 10.34 | 10.58 | 5.55 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 10.33 | 8.75 | 4.38 | ||
| 20-Day Raw Stochastic | 83.33% | 79.14% | 83.83% | ||
| 20-Day Relative Strength | 65.52 | 67.19 | 71.40 | ||
| Weighted Alpha | +6.50 | +36.78 | +103.38 | ||
| Today's Opinion | 100% Buy | 100% Buy | 56% Buy | ||
| Yesterday's Opinion | 100% Buy | 100% Buy | 48% Buy | ||
| Last Month's Opinion | 100% Buy | 56% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.15% since 06/23/23 | +9.70% since 08/13/26 | +22.02% since 08/13/26 | ||
| Low | 10.33 on 06/28/23 | 9.07 on 08/14/26 | 4.29 on 08/14/26 | ||
| High | 10.36 on 06/30/23 | 11.15 on 08/17/26 | 5.78 on 08/19/26 | ||
| 1-Month | |||||
| %Chg | +0.38% since 05/30/23 | +42.18% since 07/20/26 | +46.36% since 07/20/26 | ||
| Low | 10.30 on 06/01/23 | 6.50 on 08/03/26 | 3.56 on 07/23/26 | ||
| High | 10.36 on 06/30/23 | 11.15 on 08/17/26 | 5.78 on 08/19/26 | ||
| 3-Month | |||||
| %Chg | +1.27% since 03/30/23 | +53.08% since 05/20/26 | +36.43% since 05/20/26 | ||
| Low | 10.22 on 04/10/23 | 6.24 on 06/16/26 | 3.56 on 07/23/26 | ||
| High | 10.46 on 04/12/23 | 11.15 on 08/17/26 | 5.78 on 08/19/26 | ||
| 6-Month | |||||
| %Chg | +2.99% since 12/30/22 | +91.35% since 02/20/26 | +38.52% since 02/20/26 | ||
| Low | 10.04 on 01/04/23 | 4.50 on 03/30/26 | 3.56 on 07/23/26 | ||
| High | 10.92 on 01/12/23 | 11.15 on 08/17/26 | 5.78 on 08/19/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 330,061 | 331,715 | 326,370 | ||
| Shares Outstanding, K | 31,890 | 32,585 | 60,105 | ||
| Annual Sales, $M | 0 | 0 | 33,480,000 | ||
| Annual Net Income, $M | 2,740,000 | -51,040,000 | -52,700,000 | ||
| Last Qtr Sales, $M | 0 | 0 | 90,000 | ||
| Last Qtr Income, $M | 2,460,000 | -13,950,000 | -23,760,000 | ||
| 60-Month Beta | 0.01 | 3.37 | 0.50 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 05/15/23 | -0.26 on 08/11/26 | -0.38 on 08/10/26 | ||
| Latest Earnings Date | 01/01/70 | 11/12/26 | 11/09/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||